SELLAS Life Sciences Group, Inc. SLS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.13M+8.4% | $4.73M+12.2% | $4.22M+8.9% | $3.87M+20.8% | $3.21M-27.8% | ||
| $4.12M— | —— | —— | —— | $2.86M— | ||
| $9.25M+12.1% | $8.26M+16.5% | $7.08M+3.1% | $6.87M+13.4% | $6.06M-12.4% | ||
| -$9.25M-12.1% | -$8.26M-16.5% | -$7.08M-3.1% | -$6.87M-13.4% | -$6.06M+12.4% | ||
| $845K+41.5% | $597K+104% | $292K+7.4% | $272K+8.8% | $250K+38.1% | ||
| -$8.41M-9.8% | -$7.66M-12.8% | -$6.79M-2.9% | -$6.6M-13.6% | -$5.81M+13.7% | ||
| -$0.050.0% | -$0.05+16.7% | -$0.06+14.3% | -$0.070.0% | -$0.07+12.5% | ||
| -$9.25M-12.1% | -$8.26M-16.5% | -$7.08M-3.1% | -$6.87M-13.4% | -$6.06M+12.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is SELLAS Life Sciences Group, Inc. profitable?
- SELLAS Life Sciences Group, Inc. is not currently profitable: it reported a net loss of $29.5M over the trailing twelve months, a -4130.1% net margin.
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- Gross margin is 90.0% and operating margin is -4195.0%, with a -4130.1% net margin.
- What is SELLAS Life Sciences Group, Inc.'s earnings per share?
- SELLAS Life Sciences Group, Inc.'s diluted EPS over the trailing twelve months is $-0.23.
- Where does SELLAS Life Sciences Group, Inc.'s income statement data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.